BMI1 and non-small cell lung carcinoma: Accordingly, the aim of our current study was to assess BMI1 mRNA expression in whole blood and to evaluate its impact of expression levels on treatment response and prognosis in advanced NSCLC patients treated with platinum-based first-line chemotherapy.